TCR2 Therapeutics Inc. (TCRR) — Analyst outlook / Analyst consensus target is. Based on 9 analyst ratings, the consensus is bullish — 2 Buy, 6 Hold, 1 Sell.
The consensus price target is $5.00, representing an upside of 237.8% from the current price $1.48.
TCRR Stock — 12-Month Price Forecast
$5.00
▲ +237.84% Upside
Average Price Target
Based on 9 Wall Street analysts offering 12-month price targets for TCR2 Therapeutics Inc., the price target is $5.00.
The average price target represents a +237.84% change from the last price of $1.48.
TCRR Analyst Ratings
Hold
Based on 9 analysts giving stock ratings to TCR2 Therapeutics Inc. in the past 3 months
